期刊文献+

聚乳酸-羟基乙酸聚合物载入羟基喜树碱载药纳米粒子的制备及表征 被引量:2

Preparation and Characterization of Poly(lactic-co-glycolic acid) Nanoparticles Containing Hydroxycamptothecin
下载PDF
导出
摘要 以抗癌药物羟基喜树碱作为模型药物,可降解材料聚乳酸-羟基乙酸(PLGA)为药物负载体,采用溶剂-抗溶剂沉淀法制备聚乳酸-羟基乙酸/羟基喜树碱的载药纳米微球,考察不同溶剂-反溶剂体系对载药包封效果的影响。结果表明,以丙酮-水为溶剂体系制备的载药微球性能较好,形貌外观呈圆球形,球表面圆润光滑,粒度均一,分散效果良好,平均粒径为160 nm,载药微球包封率随着载药量的增加而减小,实测载药量为7.83%的PLGA载药微球,其载药包封率为87.68%,在28 d后溶出累计量约50%,可见以聚乳酸-羟基乙酸为载体制备的羟基喜树碱剂型,缓释作用良好。 The poly(lactic-co-glycolic acid)(PLGA)nano-microspheres containing hydroxycamptothecin(HCPT)was prepared using solvent and anti-solvent precipitation method with HCPT as the model drug,degradablePLGA as the carrier.The effects of different solvents and anti-solvents system on the drug loading capacityand entrapment efficiency were investigated.The results showed that the microspheres prepared withacetone-water as solvent system had better performance,spherical appearance,round and smooth surface,uniform particle size(the average particle size of160nm)and good dispersion.The entrapment efficiency ofdrug-loaded microspheres decreased with the increase of drug loading.It was found that the entrapmentefficiency was87.68%in the HCPT/PLGA microspheres when drug loading was7.83%.The cumulativerelease amount was50%after28days.This HCPT/PLGA drug delivery system clearly demonstrated itsgood sustained-release effect.
作者 李瑞端 张建军 Li Ruiduan;Zhang Jianjun(Jilin Institute of Chemical Technology, Jilin 132022, China;Beijing University of Chemical Technology, Beijing 100029, China)
出处 《化学反应工程与工艺》 CAS CSCD 北大核心 2016年第6期542-546,共5页 Chemical Reaction Engineering and Technology
基金 吉林省教育厅项目(2013324) 吉林市科技局青年基金项目(20156421)
关键词 羟基喜树碱 聚乳酸-羟基乙酸 纳米粒子 hydroxycamptothecin poly(lactic-co-glycolic acid) nanoparticle
  • 相关文献

参考文献5

二级参考文献22

  • 1Zhang R,Li Y,Cai Q,et al.Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I[J]. Cancer Chemother Pharmacol,1998,41(4):257-267. 被引量:1
  • 2Hatefi A,Amsden B. Camptothecin delivery methods[J]. Pharm Res,2002,19(10):1389-1399. 被引量:1
  • 3Shenderova A,Burke TG,Schwendeman SP. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins[J]. Pharm Res,1999,16(2):241-248. 被引量:1
  • 4Chow DS,Gong L,Wolfe MD,et al. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin[J]. Ann N Y Acad Sci,2000,922:164-174. 被引量:1
  • 5Tardi P,Choice E,Masin D,et al.Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models[J]. Cancer Res,2000,60(13):3389-3393. 被引量:1
  • 6M. Jayne Lawrence,Gareth D. Rees,Microemulsion-based media as novel drug delivery systems[J].Adv. Drug Deliv Rev,2000,45(1):89-121. 被引量:1
  • 7张志荣,路伟.肝靶向羟基喜树碱缓释毫微粒的研究[J].药学学报,1997,32(3):222-227. 被引量:65
  • 8Norbert Rasenack,Bernd W. Müller.Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs[J].Pharmaceutical Research.2002(12) 被引量:1
  • 9Shobha N Bhattachar,James A Wesley,Ann Fioritto,Peter J Martin,Suresh R Babu.Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus[J].International Journal of Pharmaceutics.2002(1) 被引量:1
  • 10Juhani Posti,Kirsi Katila,Timo Kostiainen.Dissolution rate limited bioavailability of flutamide, and in vitro – in vivo correlation[J].European Journal of Pharmaceutics and Biopharmaceutics.2000(1) 被引量:1

共引文献60

同被引文献36

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部